Loading
Latest filing published 05 Jan 2023 for ENvue Medical, Inc., €12k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Thomas Mika span 2 companies, the busiest being Rennova Health, Inc. and ENvue Medical, Inc. Over a trading history stretching from 15 November 2006 to 5 January 2023, the count stands at 9 filings.
On the market, this insider has only ever bought: 1 purchase, €12k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 7 share grants and 1 option exercise. 2023 to date brings 1 purchase and no sales.
The record was last updated on 5 January 2023 with an open-market purchase (€12k) in ENvue Medical, Inc. Typically, a trade is published a median of 7 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations